Christopher E. Frantz

474 total citations
10 papers, 388 citations indexed

About

Christopher E. Frantz is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Christopher E. Frantz has authored 10 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Organic Chemistry. Recurrent topics in Christopher E. Frantz's work include Carcinogens and Genotoxicity Assessment (5 papers), Cancer therapeutics and mechanisms (3 papers) and Indoor Air Quality and Microbial Exposure (2 papers). Christopher E. Frantz is often cited by papers focused on Carcinogens and Genotoxicity Assessment (5 papers), Cancer therapeutics and mechanisms (3 papers) and Indoor Air Quality and Microbial Exposure (2 papers). Christopher E. Frantz collaborates with scholars based in United States and United Kingdom. Christopher E. Frantz's co-authors include Kenneth W. Turteltaub, John S. Vogel, David A. Eastmond, Nancy H. Shen, A. Wren, Michael Cleary, Kathryn M. Mayer, Karen H. Dingley, Robert J. Mauthe and R. Colin Garner and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Environmental Health Perspectives and Carcinogenesis.

In The Last Decade

Christopher E. Frantz

10 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher E. Frantz United States 9 158 156 67 48 48 10 388
Esther A. Ubick United States 8 151 1.0× 129 0.8× 55 0.8× 19 0.4× 32 0.7× 15 345
Louise Latriano United States 12 170 1.1× 251 1.6× 160 2.4× 41 0.9× 33 0.7× 22 538
J.H. Weisburger United States 9 177 1.1× 159 1.0× 54 0.8× 50 1.0× 29 0.6× 13 589
Donald E. Nerland United States 15 188 1.2× 128 0.8× 44 0.7× 15 0.3× 33 0.7× 30 471
Karen Yeowell-O’Connell United States 14 161 1.0× 307 2.0× 206 3.1× 28 0.6× 28 0.6× 15 496
K Wakabayashi Japan 6 256 1.6× 276 1.8× 81 1.2× 27 0.6× 90 1.9× 9 569
Edward S. Riccio United States 18 191 1.2× 297 1.9× 177 2.6× 38 0.8× 57 1.2× 30 643
G. David McCoy United States 16 297 1.9× 274 1.8× 108 1.6× 48 1.0× 79 1.6× 41 853
Ruth Young United States 8 312 2.0× 190 1.2× 52 0.8× 13 0.3× 76 1.6× 11 526
Nobuyuki Ito Japan 11 178 1.1× 177 1.1× 62 0.9× 16 0.3× 37 0.8× 14 423

Countries citing papers authored by Christopher E. Frantz

Since Specialization
Citations

This map shows the geographic impact of Christopher E. Frantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Frantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Frantz more than expected).

Fields of papers citing papers by Christopher E. Frantz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher E. Frantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Frantz. The network helps show where Christopher E. Frantz may publish in the future.

Co-authorship network of co-authors of Christopher E. Frantz

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher E. Frantz. A scholar is included among the top collaborators of Christopher E. Frantz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher E. Frantz. Christopher E. Frantz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Frantz, Christopher E., et al.. (2005). Gene expression profiling of mouse host response to Listeria monocytogenes infection. Genomics. 86(6). 657–667. 10 indexed citations
2.
Wren, A., et al.. (2002). 90-Day Oral Toxicity Study of a Grape Seed Extract (IH636) in Rats. Journal of Agricultural and Food Chemistry. 50(7). 2180–2192. 90 indexed citations
3.
Schuler, Maik, et al.. (2001). Characterization and mechanisms of chromosomal alterations induced by benzene in mice and humans.. PubMed. 1–68; discussion 69. 32 indexed citations
4.
Frantz, Christopher E., et al.. (1997). Bimolane: in vitro inhibitor of human topoisomerase II. Cancer Letters. 120(2). 135–140. 8 indexed citations
5.
Turteltaub, Kenneth W., Robert J. Mauthe, Karen H. Dingley, et al.. (1997). MeIQx-DNA adduct formation in rodent and human tissues at low doses. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 376(1-2). 243–252. 61 indexed citations
6.
Frantz, Christopher E., et al.. (1996). Inhibition of human topoisomerase II in vitro by bioactive benzene metabolites.. Environmental Health Perspectives. 104(suppl 6). 1319–1323. 55 indexed citations
7.
Frantz, Christopher E., Hongwei Chen, & David A. Eastmond. (1996). Inhibition of Human Topoisomerase II in Vitro by Bioactive Benzene Metabolites. Environmental Health Perspectives. 104. 1319–1319. 13 indexed citations
8.
Frantz, Christopher E., et al.. (1995). Dose-response studies of MeIQx in rat liver and liver DNA at low doses. Carcinogenesis. 16(2). 367–373. 57 indexed citations
9.
Turteltaub, Kenneth W., John S. Vogel, Christopher E. Frantz, Michael H. Buonarati, & James S. Felton. (1993). Low-level biological dosimetry of heterocyclic amine carcinogens isolated from cooked food.. Environmental Health Perspectives. 99. 183–186. 14 indexed citations
10.
Turteltaub, Kenneth W., John S. Vogel, Christopher E. Frantz, & Nancy H. Shen. (1992). Fate and distribution of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in mice at a human dietary equivalent dose.. PubMed. 52(17). 4682–7. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esther A. Ubick Breakdown of academic impact, for papers by Louise Latriano Breakdown of academic impact, for papers by J.H. Weisburger Breakdown of academic impact, for papers by Donald E. Nerland Breakdown of academic impact, for papers by Karen Yeowell-O’Connell Breakdown of academic impact, for papers by K Wakabayashi Breakdown of academic impact, for papers by Edward S. Riccio Breakdown of academic impact, for papers by G. David McCoy Breakdown of academic impact, for papers by Ruth Young Breakdown of academic impact, for papers by Nobuyuki Ito
Rankless by CCL
2026